Tema Oncology ETF (CANC) Dividend Yield, Date & History $38.12 -0.02 (-0.05%) As of 05/22/2026 03:59 PM Eastern Add Compare Share Share Dividend Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Oncology ETF Dividend SummaryDividend Yield1.89%Annual Dividend$0.72Recent Dividend Payment Dec. 11 Tema Oncology ETF (CANC) pays an annual dividend of $0.72 per share, with a dividend yield of 1.89%. The most recent none payment of $0.0196 per share was paid on Thursday, December 11, to investors who owned the stock before the ex-dividend date of Wednesday, December 10. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Dividend HistoryCANC Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of Tema Oncology ETF's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open Tema Oncology ETF in Dividend Calculator CANC Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks Tema Oncology ETF's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open Tema Oncology ETF in Dividend Yield Calculator Tema Oncology ETF vs. The CompetitionCompare Tema Oncology ETF's annual dividend and yield with averages for and NASDAQ companies to evaluate its performance against the market.TypeTema Oncology ETF CompaniesNASDAQ CompaniesAnnual Dividend$0.72$0.02$1.63Dividend Yield1.89%15.26%5.28% Tema Oncology ETF Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame Start Date End Date Export AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date12/9/2025annual$0.0196-$0.708797.31%0.06%12/10/202512/10/202512/11/202512/10/2024$0.7283+$0.5792388.41%12/11/202412/11/202412/12/2024This table shows Tema Oncology ETF's dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. Tema Oncology ETF Dividend - Frequently Asked Questions What is Tema Oncology ETF's dividend yield? The current dividend yield for Tema Oncology ETF is 1.89%. Learn more on CANC's dividend yield history. How much is Tema Oncology ETF's annual dividend? The annual dividend for CANC shares is $0.72. Learn more on CANC's annual dividend history. How often does Tema Oncology ETF pay dividends? Tema Oncology ETF pays none dividends to shareholders. When was Tema Oncology ETF's most recent dividend payment? Tema Oncology ETF's most recent none dividend payment of $0.0196 per share was made to shareholders on Thursday, December 11, 2025. When was Tema Oncology ETF's most recent ex-dividend date? Tema Oncology ETF's most recent ex-dividend date was Wednesday, December 10, 2025. When did Tema Oncology ETF last increase or decrease its dividend? The most recent change in the company's dividend was a decrease of $0.7087 on Tuesday, December 9, 2025. More Dividend Resources from MarketBeat Related Companies SDG Dividend COPJ Dividend FINX Dividend NZAC Dividend KOID Dividend ELFY Dividend CHGX Dividend EMXF Dividend QQMG Dividend FBOT Dividend Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles Target Shows Strengths, But Analysts Want to See MoreFreight Boom: The Hormuz Blockade Payday3 Dividend Stocks With Insiders Buying in 2026From High-Yield to High-Growth: 3 Stocks Boosting DividendsDividend Growth or High Yield: The Income Investor's BetAirplane Maintenance Companies That Keep Flights Moving Are Ready to SoarAI Dividend Increases: 3 Massive Winners Boosting PayoutsMarketBeat Week in Review – 05/04 - 05/08Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches This page (NASDAQ:CANC) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
